Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avidity Biosciences Inc
(NQ:
RNA
)
43.52
+0.67 (+1.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avidity Biosciences Inc
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
What 10 Analyst Ratings Have To Say About Avidity Biosciences
May 17, 2023
Via
Benzinga
Avidity Biosciences Touts Encouraging Data From Myotonic Dystrophy Type 1 Study
April 28, 2023
Avidity Biosciences Inc (NASDAQ: RNA) announced
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
May 22, 2023
Via
Benzinga
After Falling 18% in 1 Day, Is This Growth Stock Done For?
April 11, 2023
It's too soon to predict doom, but that doesn't mean things are good.
Via
The Motley Fool
The Latest Analyst Ratings for Avidity Biosciences
March 31, 2023
Via
Benzinga
FDA Eases Partial Hold On Avidity Biosciences' Investigational Drug Study In Type Of Dystrophy
May 17, 2023
The FDA has eased the partial clinical hold on Avidity Biosciences Inc's (NASDAQ: RNA) AOC 1001, allowing Avidity to double the number of participants in the MARINA Open-Label Extension (MARINA-OLE)...
Via
Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 28, 2023
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
Via
Benzinga
US Stocks Mixed; Amazon Posts Upbeat Results
April 28, 2023
U.S. stocks traded mixed this morning, following the release of several earnings reports. Following the market opening Friday, the Dow traded up 0.11% to 33,863.22 while the NASDAQ fell 0.25% to...
Via
Benzinga
Expert Ratings for Avidity Biosciences
March 31, 2023
Via
Benzinga
Why Avidity Biosciences Shares Are Sliding Today
March 30, 2023
Via
Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
March 31, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 30, 2023
Via
Benzinga
Expert Ratings for Avidity Biosciences
March 01, 2023
Via
Benzinga
Expert Ratings for Avidity Biosciences
December 14, 2022
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Avidity Bio Crashes 26% After 'Rarer Than Rare' Event Sidelines Key Study
March 30, 2023
The company is working on a treatment for an inherited muscle-wasting disease.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
Analyst Says This Small Cap Biotech Firm Has 'Very Valuable Therapeutic,' Upgrades Stock
February 27, 2023
Via
Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
Peering Into Avidity Biosciences's Recent Short Interest
January 03, 2023
Avidity Biosciences's (NASDAQ:RNA) short percent of float has fallen 26.62% since its last report. The company recently reported that it has 6.51 million shares sold short, which is 11.33% of all...
Via
Benzinga
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
December 15, 2022
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....
Via
Benzinga
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 15, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Tesla, Amazon, Novavax, Lennar Corp, Avidity Biosciences: Why These 5 Stocks Are Drawing Retail Investors' Attention Today
December 14, 2022
Major Wall Street indices closed in the red on Wednesday despite an anticipated 50 basis points hike by the Federal Reserve as Chair Jerome Powell indicated the need for more data before the central...
Via
Benzinga
Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps
December 14, 2022
U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision.
Via
Benzinga
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
December 14, 2022
Business wins are shining the spotlight on these two companies.
Via
The Motley Fool
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.